Literature DB >> 8674846

A 338-bp proximal fragment of the glucose transporter type 2 (GLUT2) promoter drives reporter gene expression in the pancreatic islets of transgenic mice.

G Waeber1, T Pedrazzini, O Bonny, C Bonny, M Steinmann, P Nicod, J A Haefliger.   

Abstract

The high Km glucose transporter GLUT2 is a membrane protein expressed in tissues involved in maintaining glucose homeostasis, and in cells where glucose-sensing is necessary. In many experimental models of diabetes, GLUT2 gene expression is decreased in pancreatic beta-cells, which could lead to a loss of glucose-induced insulin secretion. In order to identify factors involved in pancreatic beta-cell specific expression of GLUT2, we have recently cloned the murine GLUT2 promoter and identified cis-elements within the 338-bp of the proximal promoter capable of binding islet-specific trans-acting factors. Furthermore, in transient transfection studies, this 338-bp fragment could efficiently drive the expression of the chloramphenicol acetyl transferase (CAT) gene in cell lines derived from the endocrine pancreas, but displayed no promoter activity in non-pancreatic cells. In this report, we tested the cell-specific expression of a CAT reporter gene driven by a short (338 bp) and a larger (1311 bp) fragment of the GLUT2 promoter in transgenic mice. We generated ten transgenic lines that integrated one of the constructs. CAT mRNA expression in transgenic tissues was assessed using the RNAse protection assay and the quantitative reverse transcribed polymerase chain reaction (RT-PCR). Overall CAT mRNA expression for both constructs was low compared to endogenous GLUT2 mRNA levels but the reporter transcript could be detected in all animals in the pancreatic islets and the liver, and in a few transgenic lines in the kidney and the small intestine. The CAT protein was also present in Langerhans islets and in the liver for both constructs by immunocytochemistry. These findings suggest that the proximal 338 bp of the murine GLUT2 promoter contain cis-elements required for the islet-specific expression of GLUT2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8674846     DOI: 10.1016/0303-7207(95)96801-n

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  7 in total

1.  cAMP prevents the glucose-mediated stimulation of GLUT2 gene transcription in hepatocytes.

Authors:  F Rencurel; G Waeber; C Bonny; B Antoine; P Maulard; J Girard; A Leturque
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

2.  The transcriptional repressor REST determines the cell-specific expression of the human MAPK8IP1 gene encoding IB1 (JIP-1).

Authors:  A Abderrahmani; M Steinmann; V Plaisance; G Niederhauser; J A Haefliger; V Mooser; C Bonny; P Nicod; G Waeber
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Functional properties and genomics of glucose transporters.

Authors:  Feng-Qi Zhao; Aileen F Keating
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

4.  Requirement of glucose metabolism for regulation of glucose transporter type 2 (GLUT2) gene expression in liver.

Authors:  F Rencurel; G Waeber; B Antoine; F Rocchiccioli; P Maulard; J Girard; A Leturque
Journal:  Biochem J       Date:  1996-03-15       Impact factor: 3.857

5.  Cdc42 Promotes ADSC-Derived IPC Induction, Proliferation, And Insulin Secretion Via Wnt/β-Catenin Signaling.

Authors:  Xing-Hua Xiao; Qi-Yuan Huang; Xian-Ling Qian; Jing Duan; Xue-Qiao Jiao; Long-Yuan Wu; Qing-Yun Huang; Jun Li; Xing-Ning Lai; Yu-Bo Shi; Li-Xia Xiong
Journal:  Diabetes Metab Syndr Obes       Date:  2019-11-13       Impact factor: 3.168

6.  Glucose: an energy currency and structural precursor in articular cartilage and bone with emerging roles as an extracellular signaling molecule and metabolic regulator.

Authors:  Ali Mobasheri
Journal:  Front Endocrinol (Lausanne)       Date:  2012-12-17       Impact factor: 5.555

Review 7.  Glucose transporters in pancreatic islets.

Authors:  Constantin Berger; Daniela Zdzieblo
Journal:  Pflugers Arch       Date:  2020-05-12       Impact factor: 3.657

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.